New Features! JNCN is calling for contributions for new sections that highlight treatment, education, global perspectives, and icons in neuropsychiatry. See the author guidelines for more details.
New Consensus Clinical Guidance on Management of COVID-19 Encephalopathy Accepted by JNCN
COVID-19 encephalopathy is a disturbance of brain function that may develop in persons with COVID-19. This condition may present clinically as delirium, subsyndromal delirium, or coma and negatively affects clinical outcomes. While research into the biological mechanisms of COVID-19 encephalopathy are ongoing, clinicians are in need of practical guidance on the evaluation and management of patients with this condition.JNCN has accepted for publication the Clinical Consensus Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients developed by the Global COVID-19 NeuroResearch Coalition. This document provides much-needed and immediately applicable guidance on the evaluation and management of this condition and is available here for review and download.
Latest Articles
Trending Articles in JNCN
Predisposing Risk Factors for Functional Limb Weakness: A Case-Control StudyHiding in Plain Sight: Functional Neurological Disorders in the News
The Neural Correlates of Impaired Self-Monitoring Among Individuals With Neurodegenerative Dementias
Learn more about Altmetric badges.